Citrullinated proteins: Sparks that may ignite the fire in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 6, Issue 3, 2004, Pages 107-111

  Vossenaar, Erik R ^a   van Venrooij, Walther J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti CCP autoantibodies; Citrullination; Peptidylarginine deiminase; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY; CITRULLINE; DNA; FIBRIN; HISTONE; HLA DR4 ANTIGEN; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; PROTEIN ARGININE DEIMINASE; VIMENTIN;

ANTIBODY SPECIFICITY; ARTICLE; CALCIUM CELL LEVEL; DNA POLYMORPHISM; GENETIC PREDISPOSITION; HAPLOTYPE; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PROTEIN PROCESSING; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; SYNOVIUM; T LYMPHOCYTE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; HUMANS; INFLAMMATION; PEPTIDES, CYCLIC;

EID: 2942555614     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Vossenaar ER, van Venrooij WJ: Anti-CCP antibodies, a specific marker for (early) rheumatoid arthritis. Clin Applied Immunol Rev 2004, 4:239-262.
2. van Venrooij WJ, Hazes JM, Visser H: Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002, 60: 383-388.
3. Vasishta A: Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab 2002, 21:34-36.
4. Pinheiro GC, Scheinberg MA, Aparecida-da Silva M, Maciel S: Anti-cyclic citrullinated peptide antibodies in advanced rheumatoid arthritis. Ann Intern Med 2003, 139:234-235.
5. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, Toes REM, Huizinga TW: In undifferentiated arthritis, autoantibodies to cyclic citrullinated peptides (CCP) predict progression to rheumatoid arthritis: a prospective cohort study. Arthritis Rheum 2004, 50:709-715.
6. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B: Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003, 62:120-126.
7. Vossenaar ER, Zendman AJW, van Venrooij WJ: Citrullination, a possible functional link between susceptibility genes and rheumatoid arthritis. Arthritis Res Ther 2004, 6:3-7.
8. Masson-Bessière C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, Durroux R, Cantagrel A, Serre G: In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000, 119:544-552.
9. Reparon-Schuijt CC, van Esch WJ, van Kooten C, Schellekens GA, de Jong BA, van Venrooij WJ, Breedveld FC, Verweij CL: Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. Arthritis Rheum 2001, 44: 41-47.
10. Vossenaar ER, Zendman AJW, van Venrooij WJ, Pruijn G: PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118.
11. Vossenaar ER, Radstake TR, van der Heijden A, van Mansum WAM, Dieteren C, de Rooij DJ, Barrera P, Zendman AJW, van Venrooij WJ: Expression and activity of citrullinating PAD enzymes in monocytes and macrophages. Ann Rheum Dis 2004, 63:373-381.
12. Takahara H, Okamoto H, Sugawara K: Calcium-dependent properties of peptidylarginine deiminase from rabbit skeletal muscle. Agric Biol Chem 1986, 50:2899-2904.
13. Schwab BL, Guerini D, Didszun C, Bano D, Ferrando-May E, Fava E, Tam J, Xu D, Xanthoudakis S, Nicholson DW, Carafoli E, Nicotera P: Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ 2002, 9:818-831.
14. i) is consistently required to induce the execution phase of apoptosis. Cell Death Differ 2002, 9:561-573.
15. Asaga H, Yamada M, Senshu T: Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophys Res Commun 1998, 243:641-646.
16. Mizoguchi M, Manabe M, Kawamura Y, Kondo Y, Ishidoh K, Kominami E, Watanabe K, Asaga H, Senshu T, Ogawa H: Deimination of 70-kD nuclear protein during epidermal apoptotic events in vitro. J Histochem Cytochem 1998, 46:1303-1309.
17. Hagiwara T, Nakashima K, Hirano H, Senshu T, Yamada M: Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 2002, 290:979-983.
18. Nakashima K, Hagiwara T, Yamada M: Nuclear localization of peptidylarginine deiminase V and histone deimination in granulocytes. J Biol Chem 2002, 277:49562-49568.
19. Tak PP, Firestein GS: Apoptosis in rheumatoid arthritis. In Apoptosis and inflammation. Edited by Winkler JD. Basel, Switzerland: Birkhauser Verlag; 1999:149-162.
20. Senshu T, Kan S, Ogawa H, Manabe M, Asaga H: Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 1996, 225:712-719.
21. Vossenaar ER, Despres N, Lapointe E, van der Heijden A, Lora M, Senshu T, van Venrooij WJ, Menard HA: Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther 2004, 6:R142-R150.
22. Despres N, Boire G, Lopez-Longo FJ, Menard HA: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J Rheumatol 1994, 21:1027-1033.
23. Menard HA, Lapointe E, Rochdi MD, Zhou ZJ: Insights into rheumatoid arthritis derived from the Sa immune system. Arthritis Res 2000, 2:429-432.
24. McCarthy DJ, Cheung HS: Origin and significance of rice bodies in synovial fluid. Lancet 1982, 2:715-716.
25. Weinberg JB, Pippen AM, Greenberg CS: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1991, 34:996-1005.
26. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, Serre G: The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin. J Immunol 2001, 166:4177-4184.
27. Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, Nagasaki M, Nakayama-Hamada M, Kawaida R, Ono M, Ohtsuki M, Furukawa H, Yoshino S, Yukioka M, Tohma S, Matsubara T, Wakitani S, Teshima R, Nishioka Y, Sekine A, Iida A, Takahashi A, Tsunoda T, Nakamura Y, Yamamoto K: Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 2003, 34:395-402.
28. Chapuy-Regaud S, Sebbag M, Baeten D, Clavel C, de Keyser F, Serre G: The presence of deiminated fibrin in the synovial membrane is not specific for rheumatoid arthritis [abstract]. Arthritis Res Ther 2004, Suppl 1:S8.
29. Baeten D, Peene I, Union A, Meheus L, Sebbag M, Serre G, Veys EM, de Keyser F: Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001, 44:2255-2262.
30. Zdanski CJ, Prazma J, Petrusz P, Grossman G, Raynor E, Smith TL, Pillsbury HC: Nitric oxide synthase is an active enzyme in the spiral ganglion cells of the rat cochlea. Hear Res 1994, 79:39-47.
31. Smeets TJ, Vossenaar ER, van Venrooij WJ, Tak PP: Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al. Arthritis Rheum 2002, 46:2824-2826.
32. Vossenaar ER, Nijenhuis S, van Helsen MM, van der Heijden A, Senshu T, van den Berg WB, van Venrooij WJ, Joosten LA: Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003, 48:2489-2500.
33. Chapuy-Regaud S, Nogueira L, Clavel C, Sebbag M, Vincent C, Serre G: Subclass distribution of IgG autoantibodies to deiminated fibrinogen in rheumatoid arthritis [abstract]. Arthritis Res Ther 2003, Suppl 1:S2.
34. Meulenbroek AJ, Zeijlemaker WP: Human IgG Subclasses: Useful Diagnostic Markers for Immunocompetence, 2nd ed. Amsterdam, The Netherlands: CLB; 2000.
35. Silman AJ, Pearson JE: Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 2002, Suppl 3:S265-S272.
36. Hill JA, Southwood S, Sette A, Jevnikar AM, Bell DA, Cairns E: Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J Immunol 2003, 171:538-541.
37. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, Steiner G, Rosen A, Zhang C, Menard HA, Zhou ZJ, Palosuo T, van Venrooij WJ, Wilder RL, Klippel JH, Schumacher HRJ, El-Gabalawy HS: Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000, 2:236-243.
38. Zanelli E, Breedveld FC, de Vries RR: HLA class II association with rheumatoid arthritis: facts and interpretations. Hum Immunol 2000, 61:1254-1261.
39. Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, Sundin U, van Venrooij WJ: Antibodies against citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003, 48: 2741-2749.
40. Nielen MMJ, van Schaardenburg D, Reesink HWR, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MHM, Habibuw MR, Vandenbroucke JP, Dijkmans BA: Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
41. Matzinger P: The danger model: a renewed sense of self. Science 2002, 296:301-305.
42. Rodenburg RJ, Raats JM, Pruijn GJ, van Venrooij WJ: Cell death: a trigger of autoimmunity? Bioessays 2000, 22:627-636.